Incidence of acute cerebrovascular events in patients with rheumatic or calcific mitral stenosis: A systematic review and meta-analysis

Background: Patients with mitral stenosis (MS) may be predisposed to acute cerebrovascular events (ACE) and peripheral thromboembolic events (TEE). Concomitant atrial fibrillation (AF), mitral annular calcification (MAC) and rheumatic heart disease (RHD) are independent risk factors. Our aim was to...

Full description

Bibliographic Details
Main Authors: Qi Zhuang Siah, Bao Yu Pang, Tiffany TS. Ye, Jamie SY. Ho, Yao Hao Teo, Yao Neng Teo, Nicholas LX. Syn, Benjamin YQ. Tan, Raymond CC. Wong, Leonard LL. Yeo, Edward CY. Lee, Tony YW. Li, Kian-Keong Poh, William KF. Kong, Tiong-Cheng Yeo, Ping Chai, Ching-Hui Sia
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Hellenic Journal of Cardiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1109966622001178
_version_ 1797857723202666496
author Qi Zhuang Siah
Bao Yu Pang
Tiffany TS. Ye
Jamie SY. Ho
Yao Hao Teo
Yao Neng Teo
Nicholas LX. Syn
Benjamin YQ. Tan
Raymond CC. Wong
Leonard LL. Yeo
Edward CY. Lee
Tony YW. Li
Kian-Keong Poh
William KF. Kong
Tiong-Cheng Yeo
Ping Chai
Ching-Hui Sia
author_facet Qi Zhuang Siah
Bao Yu Pang
Tiffany TS. Ye
Jamie SY. Ho
Yao Hao Teo
Yao Neng Teo
Nicholas LX. Syn
Benjamin YQ. Tan
Raymond CC. Wong
Leonard LL. Yeo
Edward CY. Lee
Tony YW. Li
Kian-Keong Poh
William KF. Kong
Tiong-Cheng Yeo
Ping Chai
Ching-Hui Sia
author_sort Qi Zhuang Siah
collection DOAJ
description Background: Patients with mitral stenosis (MS) may be predisposed to acute cerebrovascular events (ACE) and peripheral thromboembolic events (TEE). Concomitant atrial fibrillation (AF), mitral annular calcification (MAC) and rheumatic heart disease (RHD) are independent risk factors. Our aim was to evaluate the incidence of ACEs in MS patients and the implications of AF, MAC and RHD on thromboembolic risks. Methods: This systematic review was registered on PROSPERO (CRD42021291316). Six databases were searched from inception to 19th December 2021. The clinical outcomes were composite ACE, ischaemic stroke/transient ischaemic attack (TIA) and peripheral TEE. Results: We included 16 and 9 papers, respectively, in our qualitative and quantitative analyses. The MS cohort with AF had the highest incidence of composite ACE (31.55%; 95% CI 3.60–85.03; I2 = 99%), followed by the MAC (14.85%; 95% CI 7.21–28.11; I2 = 98%), overall MS (8.30%; 95% CI 3.45–18.63; I2 = 96%) and rheumatic MS population (4.92%; 95% CI 3.53–6.83; I2 = 38%). Stroke/TIA were reported in 29.62% of the concomitant AF subgroup (95% CI 2.91–85.51; I2 = 99%) and in 7.11% of the overall MS patients (95% CI 1.91–23.16; I2 = 97%). However, the heterogeneity of the pooled incidence of clinical outcomes in all groups, except the rheumatic MS group, was substantial and significant. The logit-transformed proportion of composite ACE increased by 0.0141 (95% CI 0.0111–0.0171; p < 0.01) per year of follow-up. Conclusion: In the MS population, MAC and concomitant AF are risk factors for the development of ACE. The scarcity of data in our systematic review reflects the need for further studies to explore thromboembolic risks in all MS subtypes.
first_indexed 2024-04-09T21:01:24Z
format Article
id doaj.art-f5678bcd061a4600b87d4872c3eac776
institution Directory Open Access Journal
issn 1109-9666
language English
last_indexed 2024-04-09T21:01:24Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series Hellenic Journal of Cardiology
spelling doaj.art-f5678bcd061a4600b87d4872c3eac7762023-03-29T09:25:10ZengElsevierHellenic Journal of Cardiology1109-96662023-03-01708084Incidence of acute cerebrovascular events in patients with rheumatic or calcific mitral stenosis: A systematic review and meta-analysisQi Zhuang Siah0Bao Yu Pang1Tiffany TS. Ye2Jamie SY. Ho3Yao Hao Teo4Yao Neng Teo5Nicholas LX. Syn6Benjamin YQ. Tan7Raymond CC. Wong8Leonard LL. Yeo9Edward CY. Lee10Tony YW. Li11Kian-Keong Poh12William KF. Kong13Tiong-Cheng Yeo14Ping Chai15Ching-Hui Sia16School of Medicine, Cardiff University, Wales, United KingdomPrince Charles Hospital, Cwm Taf Morgannwg University Health Board, Wales, United KingdomSchool of Medicine, Cardiff University, Wales, United KingdomAcademic Foundation Year Programme, North Middlesex Hospital University Trust, London, United KingdomDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, SingaporeDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, SingaporeDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, SingaporeDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Neurology, Department of Medicine, National University Hospital, SingaporeDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Cardiology, National University Heart Centre Singapore, SingaporeDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Neurology, Department of Medicine, National University Hospital, SingaporeDepartment of Cardiology, National University Heart Centre Singapore, SingaporeDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Cardiology, National University Heart Centre Singapore, SingaporeDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Cardiology, National University Heart Centre Singapore, SingaporeDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Cardiology, National University Heart Centre Singapore, SingaporeDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Cardiology, National University Heart Centre Singapore, SingaporeDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Cardiology, National University Heart Centre Singapore, SingaporeCorresponding author. Department of Cardiology, National University Heart Centre Singapore, 1E Kent Ridge Road, NUHS Tower Block Level 9, 119228, Singapore. Tel: +65 6779 5555, Fax: +65 6872 2998.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Cardiology, National University Heart Centre Singapore, SingaporeBackground: Patients with mitral stenosis (MS) may be predisposed to acute cerebrovascular events (ACE) and peripheral thromboembolic events (TEE). Concomitant atrial fibrillation (AF), mitral annular calcification (MAC) and rheumatic heart disease (RHD) are independent risk factors. Our aim was to evaluate the incidence of ACEs in MS patients and the implications of AF, MAC and RHD on thromboembolic risks. Methods: This systematic review was registered on PROSPERO (CRD42021291316). Six databases were searched from inception to 19th December 2021. The clinical outcomes were composite ACE, ischaemic stroke/transient ischaemic attack (TIA) and peripheral TEE. Results: We included 16 and 9 papers, respectively, in our qualitative and quantitative analyses. The MS cohort with AF had the highest incidence of composite ACE (31.55%; 95% CI 3.60–85.03; I2 = 99%), followed by the MAC (14.85%; 95% CI 7.21–28.11; I2 = 98%), overall MS (8.30%; 95% CI 3.45–18.63; I2 = 96%) and rheumatic MS population (4.92%; 95% CI 3.53–6.83; I2 = 38%). Stroke/TIA were reported in 29.62% of the concomitant AF subgroup (95% CI 2.91–85.51; I2 = 99%) and in 7.11% of the overall MS patients (95% CI 1.91–23.16; I2 = 97%). However, the heterogeneity of the pooled incidence of clinical outcomes in all groups, except the rheumatic MS group, was substantial and significant. The logit-transformed proportion of composite ACE increased by 0.0141 (95% CI 0.0111–0.0171; p < 0.01) per year of follow-up. Conclusion: In the MS population, MAC and concomitant AF are risk factors for the development of ACE. The scarcity of data in our systematic review reflects the need for further studies to explore thromboembolic risks in all MS subtypes.http://www.sciencedirect.com/science/article/pii/S1109966622001178Mitral stenosis (MS)ischaemic strokeincidence
spellingShingle Qi Zhuang Siah
Bao Yu Pang
Tiffany TS. Ye
Jamie SY. Ho
Yao Hao Teo
Yao Neng Teo
Nicholas LX. Syn
Benjamin YQ. Tan
Raymond CC. Wong
Leonard LL. Yeo
Edward CY. Lee
Tony YW. Li
Kian-Keong Poh
William KF. Kong
Tiong-Cheng Yeo
Ping Chai
Ching-Hui Sia
Incidence of acute cerebrovascular events in patients with rheumatic or calcific mitral stenosis: A systematic review and meta-analysis
Hellenic Journal of Cardiology
Mitral stenosis (MS)
ischaemic stroke
incidence
title Incidence of acute cerebrovascular events in patients with rheumatic or calcific mitral stenosis: A systematic review and meta-analysis
title_full Incidence of acute cerebrovascular events in patients with rheumatic or calcific mitral stenosis: A systematic review and meta-analysis
title_fullStr Incidence of acute cerebrovascular events in patients with rheumatic or calcific mitral stenosis: A systematic review and meta-analysis
title_full_unstemmed Incidence of acute cerebrovascular events in patients with rheumatic or calcific mitral stenosis: A systematic review and meta-analysis
title_short Incidence of acute cerebrovascular events in patients with rheumatic or calcific mitral stenosis: A systematic review and meta-analysis
title_sort incidence of acute cerebrovascular events in patients with rheumatic or calcific mitral stenosis a systematic review and meta analysis
topic Mitral stenosis (MS)
ischaemic stroke
incidence
url http://www.sciencedirect.com/science/article/pii/S1109966622001178
work_keys_str_mv AT qizhuangsiah incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT baoyupang incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT tiffanytsye incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT jamiesyho incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT yaohaoteo incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT yaonengteo incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT nicholaslxsyn incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT benjaminyqtan incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT raymondccwong incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT leonardllyeo incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT edwardcylee incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT tonyywli incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT kiankeongpoh incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT williamkfkong incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT tiongchengyeo incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT pingchai incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis
AT chinghuisia incidenceofacutecerebrovasculareventsinpatientswithrheumaticorcalcificmitralstenosisasystematicreviewandmetaanalysis